ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases
Chronic Renal Insufficiency
Chronic Kidney Failure
IGA Glomerulonephritis
Renal Insufficiency
Renal Cell Carcinoma
Diabetes Mellitus

Kidney Disease trials near Rochester, MN, USA:

A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

is to evaluate the effect of tolvaptan on the need for renal replacement therapy in pediatric subjects with autosomal recessive polycystic kidney...

Enrolling
Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Drug: Tolvaptan (OPC-41061)

Phase 3

Otsuka
Otsuka

Rochester, Minnesota, United States and 17 other locations

To assess the impact of RGLS8429 on height-adjusted total kidney volume (htTKV)* To characterize the pharmacokinetic (PK) properties of RGLS...

Enrolling
Polycystic Kidney, Autosomal Dominant
Autosomal Dominant Polycystic Kidney Disease
Drug: RGLS8429
Drug: Placebo

Phase 1

Regulus Therapeutics

Rochester, Minnesota, United States and 27 other locations

The primary objective of this study is to evaluate the safety of tolvaptan in pediatric subjects with autosomal recessive polycystic kidney ...

Enrolling
Autosomal Recessive Polycystic Kidney (ARPKD)
Drug: Tolvaptan Suspension
Drug: Tolvaptan Tablets

Phase 3

Otsuka
Otsuka

Rochester, Minnesota, United States and 18 other locations

This study is an open-label, multi-center study evaluating the clinical utility of Renasight in the diagnosis and management of kidney disease...

Active, not recruiting
Kidney Diseases
Diagnostic Test: Renasight
Natera
Natera

Rochester, Minnesota, United States and 30 other locations

The researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in peop...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Placebo (semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Rochester, Minnesota, United States and 407 other locations

The proposed study is designed to provide patients previously enrolled in Phase 1 and 2 studies of DCR-PHXC and their siblings (\<18 years old) long-...

Invitation-only
Kidney Diseases
Genetic Disease
Drug: DCR-PHXC

Phase 3

Dicerna Pharmaceuticals

Rochester, Minnesota, United States and 22 other locations

PLD (ADPLD) or associated with autosomal dominant polycystic kidney disease (ADPKD).In the Treatment Period of the trial, participa...

Active, not recruiting
Polycystic Liver Disease
Drug: CAM2029
Drug: Placebo

Phase 2, Phase 3

Camarus

Rochester, Minnesota, United States and 10 other locations

or more. People can take part if they have cardiovascular or chronic kidney disease. People who have at least 2 health problems rel...

Enrolling
Obesity
Drug: Placebo
Drug: survodutide

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Rochester, Minnesota, United States and 539 other locations

This study will evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics (PK) of obinutuzumab compared with tacrolimus in participants w...

Active, not recruiting
Primary Membranous Nephropathy
Drug: Tacrolimus
Drug: Methylprednisolone

Phase 3

Roche
Roche

Rochester, Minnesota, United States and 55 other locations

's function. These drugs can have serious side effects and often do not cure the disease. There is a need for new treatments for MN that are...

Active, not recruiting
Membranous Nephropathy
Nephrotic Syndrome
Drug: Rituximab
Drug: Belimumab

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Rochester, Minnesota, United States and 22 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems